Meeting
2015 Gastrointestinal Cancers Symposium
Multicenter phase III trial of adjuvant chemoradiotherapy in stomach tumors 2 (ARTIST 2).
Authors
Se Hoon Park
Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea
Se Hoon Park , Su Jin Lee , Seung Tae Kim , Jeeyun Lee , Joon Oh Park , Young Suk Park , Ho Yeong Lim , Won Ki Kang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT0176146
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr TPS228)
DOI
10.1200/jco.2015.33.3_suppl.tps228
Abstract #
TPS228
Poster Bd #
E24
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Neoadjuvant S-1 plus cisplatin-based chemoradiotherapy compared with surgery alone for locally advanced gastric cancer: Randomized, phase II trial.
First Author: Moonki Hong
Poster
2016 ASCO Annual Meeting
Prognostic value of the metastatic lymph node (N) ratio in the adjuvant chemoradiotherapy in stomach tumors (ARTIST) phase III trial
First Author: Soonil Lee
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).
First Author: Izuma Nakayama
Poster
2018 Gastrointestinal Cancers Symposium
A phase II study of chemotherapy and immune checkpoint blockade with pembrolizumab in the perioperative and maintenance treatment of locoregional gastric or GE junction adenocarcinoma.
First Author: Paul Eliezer Oberstein